Humacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 6, 2024) - Humacyte, a biotechnology company focused on regenerative medicine, is now facing an investor class action alleging that the company misled investors about the status of its key product and the regulatory compliance of its manufacturing facilities. Hagens Berman urges investors in Humacyte (NASDAQ: HUMA) who suffered substantial losses to submit your losses now. Class Period: May 10, 2024 - Oct. 17, 2024 Lead Plaintiff Deadline:...
2024-12-06 10:52 AM EST
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 6, 2024) - Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they misrepresented and concealed crucial information about the company's financial performance, especially concerning its key customer, PepsiCo. Hagens Berman is investigating the allegations and urges investors in Celsius who purchased shares and suffered substantial losses to submit your...
2024-12-06 10:49 AM EST
Symbotic (SYM) Accused of Misleading Investors with Inflated Revenues - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 6, 2024) - Symbotic Inc. (NASDAQ: SYM), the automation technology company, is facing a securities fraud class action lawsuit after its stock price plummeted over 40% in a single day. The company's troubles began on November 27, 2024, when it alerted investors of a delay in filing its annual report and warned against the accuracy of previously submitted financial statements. Hagens Berman has opened an investigation and urges investors in...
2024-12-06 10:46 AM EST
ASP Isotopes (ASPI) Accused of Deceiving Investors with Bogus Nuclear Tech Claims- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 6, 2024) - ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now. Class Period: Oct. 30, 2024 - Nov. 26, 2024 Lead Plaintiff Deadline: Feb. 3,...
2024-12-06 10:43 AM EST
Edwards Lifesciences (EW) Faces Investor Class Action Lawsuit Over TAVM Platform Disclosures, Deadline Pending - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 5, 2024) - Investors in Edwards Lifesciences Corporation (NYSE: EW) contend that the medical device giant misled them about the growth prospects of its core product, the Transcatheter Aortic Valve Replacement (TAVR) platform. A class action lawsuit has been filed, accusing the company of securities fraud and claiming that executives painted a misleading picture of TAVR's future growth potential. Hagens Berman urges Edwards Lifesciences...
2024-12-05 6:03 PM EST
Elanco (ELAN) Faces Securities Class Action Lawsuit Over Alleged Safety Risks of Zenrelia, December 6th Deadline Pending - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 5, 2024) - Animal health company Elanco (ELAN) and its most senior executives are the targets of a securities class action suit, alleging that they downplayed potential safety concerns related to Elanco's new oral Janus kinase inhibitor, Zenrelia, while overstating its prospects for a rapid U.S. market entry. Hagens Berman urges Elanco Animal Health Incorporated (NYSE: ELAN) investors who suffered substantial losses to submit your losses...
2024-12-05 11:54 AM EST
iLearningEngines (AILE) Faces SEC Scrutiny and Investor Backlash Over Accounting Irregularities - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 5, 2024) - iLearningEngines (NASDAQ: AILE), an AI-powered learning automation company, has been embroiled in a series of troubling developments that have sent its stock price plummeting and caused its investors to allege claims of securities fraud. Hagens Berman urges iLearningEngines investors who suffered substantial losses to submit your losses now. iLearningEngines Replaces CFO and Warns of Financial Restatements Amid Investigation On...
2024-12-05 11:50 AM EST
Investors Claim Customers Bancorp (CUBI) Concealed Regulatory Risks - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 5, 2024) - Customer Bancorp is now the target of a securities class action, alleging that the company and certain of its top executives misled investors about its anti-money laundering practices and compliance with federal regulations. Hagens Berman urges Customers Bancorp, Inc. (NYSE: CUBI) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation...
2024-12-05 11:46 AM EST
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 4, 2024) - Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they misrepresented and concealed crucial information about the company's financial performance, especially concerning its key customer, PepsiCo. Hagens Berman is investigating the allegations and urges investors in Celsius who purchased shares and suffered substantial losses to submit your...
2024-12-04 12:28 PM EST
Acadia Healthcare (ACHC) Faces SEC Subpoena Over Admissions and Billings Practices, Stock Falls Again, Class Action Pending - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 4, 2024) - Acadia Healthcare Company (NASDAQ: ACHC) is under fire as it faces a series of securities class-action lawsuits. Investors allege the company misled them about its business practices, with the most recent lawsuit, filed on October 29, 2024, expanding the class period to end on October 18, 2024. This extension followed a report from The New York Times, which revealed that the Veterans Affairs Department had launched an...
2024-12-04 12:20 PM EST
Investors Sue PACS Group (PACS) Amid Accusations of Medicare Fraud - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 4, 2024) - PACS Group, Inc. (NYSE: PACS) and certain of its C-Suite officers are now entangled in a securities class action lawsuit, following allegations of misleading investors by engaging in deceptive Medicare practices. Hagens Berman urges investors in PACS Group who suffered substantial losses to submit your losses now. Class Period: Apr. 11, 2024 - Nov. 5, 2024 Lead Plaintiff Deadline: Jan. 13, 2025 Visit:...
2024-12-04 12:15 PM EST
Zeta Global Holdings (ZETA) Faces Investor Class Action Alleging Revenue Round-Tripping & Improper Use of Consent Farms - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 4, 2024) - Digital marketing giant Zeta Global Holdings Corp. (NYSE: ZETA) is now facing a class action lawsuit from aggrieved investors who claim they were deceived about the company's true financial health and business practices. Hagens Berman is investigating the allegations and urges investors in Zeta who purchased shares and suffered substantial losses to submit your losses now. Class Period: Feb. 27, 2024 - Nov. 13, 2024 Lead...
2024-12-04 11:17 AM EST
Humacyte (HUMA) Faces Class Action Lawsuit After FDA Inspection Reveals Manufacturing Issues- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 3, 2024) - Humacyte, Inc. (NASDAQ: HUMA) and certain of its executives are now defendants in a class action lawsuit filed in the U.S. District Court for the Middle District of North Carolina. The suit, Cutshall v. Humacyte, Inc., et al., alleges that the company misled investors about the status of its Biologic License Application (BLA) for its acellular tissue engineered vessel (ATEV) and the regulatory compliance of its manufacturing...
2024-12-03 8:14 PM EST
Symbotic (SYM) Accused of Misleading Investors with Inflated Revenues - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 3, 2024) - Symbotic Inc. (NASDAQ: SYM), the automation technology company, is facing a securities fraud class action lawsuit after its stock price plummeted over 40% in a single day. The company's troubles began on November 27, 2024, when it alerted investors of a delay in filing its annual report and warned against the accuracy of previously submitted financial statements. Hagens Berman has opened an investigation and urges investors in...
2024-12-03 6:18 PM EST
Elanco (ELAN) Hit with Investor Lawsuit Over New Drug, December 6th Deadline Pending - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 2, 2024) - A federal lawsuit has been filed in the U.S. District Court of Maryland against Elanco Animal Health Inc. and specific executives, accusing them of making false and misleading statements between November 7, 2023, and June 26, 2024. Hagens Berman urges Elanco Animal Health Incorporated (NYSE: ELAN) investors who suffered substantial losses to submit your losses now. Class Period: Nov. 7, 2023 - June 26, 2024 Lead Plaintiff...
2024-12-02 2:14 PM EST
iLearningEngines (AILE) Faces Investor Class Action - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 2, 2024) - The price of iLearningEngines (NASDAQ: AILE) shares crashed over 30% lower on November 18, 2024 after announcing that (i) the company had placed CFO S. Farhan Naqvi on administrative leave effective immediately, (ii) its outside auditor had withdrawn its prior opinions, (iii) investors should no longer rely on previously-filed financial statements, and (iv) the SEC had subpoenaed the company seeking various documents and...
2024-12-02 2:11 PM EST
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 2, 2024) - Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards...
2024-12-02 2:09 PM EST
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market Capitalization - Hagens Berman
San Francisco, California--(Newsfile Corp. - November 30, 2024) - Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 6, 2024 - July 24, 2024 Lead Plaintiff Deadline: Dec. 13, 2024 Visit: www.hbsslaw.com/investor-fraud/ew Contact the Firm Now: EW@hbsslaw.com 844-916-0895 Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards...
2024-11-30 4:23 PM EST
PACS Group (PACS) Faces Securities Class Action - Hagens Berman
San Francisco, California--(Newsfile Corp. - November 29, 2024) - PACS Group, Inc. (NYSE: PACS) and certain of its key executives have been named as defendants in a securities class action brought on behalf of PACS investors alleging violations of the U.S. securities laws. Hagens Berman has begun an investigation into the matter and urges investors in PACS Group who purchased shares pursuant to PACS' April 2024 IPO or on the post-IPO open market and suffered substantial losses to submit your...
2024-11-29 6:16 PM EST
Evolv Technologies (EVLV) CFO Now Out After CEO Terminated And After Admitting To Improper Revenue Recognition - Hagens Berman
San Francisco, California--(Newsfile Corp. - November 29, 2024) - On Nov. 21, 2024, Evolv Technologies Holdings (NASDAQ: EVLV) announced that its Chief Financial Officer Mark Donohue resigned and that he will not receive any severance payments or benefits in connection with his departure. This news follows the company's Nov. 13, 2024 disclosure that it would not timely file its quarterly report with the SEC because of its pending investigations into the company's sales practices. More...
2024-11-29 6:08 PM EST